Atopic eczema in primary care

MeReC Bulletin

Volumn 14, Issue 1, 2003, Pages 1-4

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BETAMETHASONE; BETAMETHASONE VALERATE; CORTICOSTEROID; EMOLLIENT AGENT; ERYTHROMYCIN; FLUCLOXACILLIN; FLUTICASONE PROPIONATE; HERBACEOUS AGENT; HYDROCORTISONE; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; IMMUNOSUPPRESSIVE AGENT; PIMECROLIMUS; PRIMROSE OIL; TACROLIMUS;

ANTIBIOTIC RESISTANCE; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BURNING SENSATION; CHINESE MEDICINE; CLINICAL FEATURE; CLOTHING; DERMATITIS; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG WITHDRAWAL; DRY SKIN; FAMILY HISTORY; HAY FEVER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INFECTION; LIVER DISEASE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SPECIALIST; PATIENT CARE; PATIENT COUNSELING; PATIENT REFERRAL; PHOTOTHERAPY; PRIMARY MEDICAL CARE; PRURITUS; RISK BENEFIT ANALYSIS; SKIN CARE; SKIN EXAMINATION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TEMPERATURE;

EID: 0043025124     PISSN: 14655659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Primary Care Dermatology Society and British Association of Dermatologists. Guidelines for the management of atopic eczema. 2003. Available from: URL: http://www.bad.org.uk/doctors/service%20provision/Primary/eczema.htm. Accessed 11.07.03.
2. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4(37). Available from: URL: http://www.ncchta.org/fullmono/mon437.pdf. Accessed 11.07.03.
3. Barnetson RStC, Rogers M. Childhood atopic eczema. BMJ 2002;324:1376-9.
4. Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60.
5. McHenry PM, Williams HC, Bingham EA. Fortnightly review: management of atopic eczema. BMJ 1995;310:843-7.
6. National Institute for Clinical Excellence. Atopic eczema in children - referral practice (pilot version). Available from: URL: http://www.nice.org.uk. Accessed 11.07.03
7. Smethurst D, Macfarlane S. Atopic eczema. Clinical Evidence 2003;8:1664-82.
8. Topical steroids for atopic dermatitis in primary care. Drug Ther Bull 2003;41:5-8.
9. Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 2002;324:768-71.
10. Berth-Jones J, Damstra RJ, Golsch S, at al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326: 1367-70.
11. Goodyear HM, Harper JI.'Wet wrap' dressings for eczema: an effective treatment but not to be misused [letter). Br J Dermatol 2002;146:159.
12. Public Health Laboratory Service. Management of infection guidance for primary care - draft for consultation & local adaptation. November 2002. Available from: URL: http://www.phls.org.uk/topics_az/antibiotic_guidance/ antibiotic_guidelines.doc. Accessed 11.07.03.
13. Antiseptic/emollient combinations. Drug Ther Bull 1998;36:84-6.
14. Williams H. New treatments for atopic dermatitis. BMJ 2002;324:1533-4.
15. Scottish Medicines Consortium. Tacrolimus ointment O.1% and 0.03% (Protopic) Fujisawa. Summary of Recommendation. No 12/02. October 2002. Available from: URL: http://www.htbs.co.uk/docs/pdf/TacrolimusOintmentAdvice(4-10-02).pdf. Accessed 11.07.03.
16. Scottish Medicines Consortium. Pimecrolimus 1% cream (Elidel) Novartis Pharmaceuticals UK Ltd. Summary of Recommendation. No. 35/03. May 2003. Available from:URL: http://www.htbs.co.uk/docs/pdf/PimecrolimusCream(Elidel)090503.pdf. Accessed 11.07.03.
17. Topical tacrolimus - a role in atopic dermatitis? Drug Ther Bull 2002;40:73-5.
18. Pimecrolimus cream for atopic dermatitis. Drug Ther Bull 2003;41:33-6.
19. Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-55.
20. Reitamo S, Van Leent EJM, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-A6.
21. Luger T, van Leent EJM, Graeber M, et al. SDZASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001;144:788-94.
22. Meurer M, Folster-Holst R, Wozel G, et al. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology 2002;205:271-7.
23. Wahn U, Bos JD, Goodfield M, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002;110(1):e2.
24. Kapp A, Papp K, Bingham A, et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 2002;110:277-84.
25. Klein PA, Clark RAF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999;135:1522-5.
26. MCA/CSM. Withdrawal of Epogam and Efamast. Curr Problems Pharmacovigilance 2002;28:12. Available from: URL: http://www.mca.gov.uk/aboutagency/regframework/csm/csmhome.htm. Accessed 11.07.03.